Life science credit company Symbiotic Capital launches with $600m
Symbiotic Capital is a life sciences-focused credit entity associated with investment company Bellco Capital.
07 August 2024
07 August 2024
Symbiotic Capital is a life sciences-focused credit entity associated with investment company Bellco Capital.
A study by Mendel and UMass Amherst shows different types of hallucinations in AI-summarised medical records and the need for robust detection.
The funding round was led by SV Health Investors, with contributions from 1315 Capital and existing investor RC Capital.
The Moda-flx system enables clinicians to tailor haemodialysis treatments to individual patient needs within one integrated system.
Chest analysis software INSIGHT CXR demonstrated superior performance in TB detection compared to 11 other AI-based products.
The device does not require any additional chemicals or procedures.
The company's gounder and owner Elon Musk said the implantation went “extremely well” but remained tight-lipped on further details.
3D printing in healthcare is making key breakthroughs, bringing us closer to the possibility of 3D-printed organs.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.